About Us
Our Mission
Leadership
Partnerships
Careers
Contact Us
Our Science
SCY-247
Ibrexafungerp
Life-threatening Infections
MARIO
Community Infections
Pipeline
Publications and Presentations
Product
News
News
Events
Careers
Investors
Our Science
SCY-247
Ibrexafungerp
Life-threatening Infections
Invasive Fungal Infections
Invasive Candidiasis
Invasive Aspergillosis
MARIO
Community Infections
Vulvovaginal Candidiasis
Recurrent VVC
Pipeline
Publications and Presentations
Our Science
Publications and Presentations
Date
Title
June 2017
Lack of an Effect of SCY-078, a Novel Antifungal Agent on QTc Interval in Healthy Subjects
G. Murphy, B. Darpo, T. Marbury, M. Hyman, D. Angulo
ASM Microbe 2017
June 2017
Assessment of the
In Vitro
Antifungal Activity of SCY-078 Against a Panel of Susceptible and Resistant, Clinical
Candida
Isolates from Europe
K. Borroto-Esoda, S. Birchall, C. B. Moore, D. Angulo
ASM Microbe 2017
April 2017
The Novel Oral Glucan Synthase Inhibitor SCY-078 Shows
In Vitro
Activity Against
Candida
spp. Bioflms
J. Guinea, L. Marcos-Zambrano, M. Gomez-Perosanz, P. Escribano, E. Bouza Santiago
27th European Congress of Clinical Microbiology and Infectious Diseases
April 2017
Activity of SCY-078 against
Candida
spp. obtained by EUCAST and CLSI procedures
L. Marcos-Zambrano, M. Gómez-Perosanz, P. Escribano, E. Bouza Santiago, J.Guinea
27th European Congress of Clinical Microbiology and Infectious Diseases
April 2017
Effect of SCY-078 on the Pharmacokinetics of Tacrolimus: Results from a Phase 1 Clinical Drug-Drug Interaction Trial
D. Angulo, G. Atiee, C. Corr, M. Willett, G. Murphy, S. Wring
27th European Congress of Clinical Microbiology and Infectious Diseases
April 2017
Effect of SCY-078 on the Pharmacokinetics of CYP2C8 substrate (Rosiglitazone) – Results from a Phase 1 Clinical Trial
D. Angulo, G. Atiee, C. Corr, M. Willett, G. Murphy, S. Wring
27th European Congress of Clinical Microbiology and Infectious Diseases
April 2017
Evaluation of Antifungal Activity of SCY-078 in Combination with Other Antifungals Against
Aspergillus
Strains
L. Long, E. Larkin, K. Borroto-Esoda, S. Wring, D. Angulo, M. Ghannoum
27th European Congress of Clinical Microbiology and Infectious Diseases
April 2016
SCY-078 Displays Significant
In Vitro
Activity Against Multi Drug Resistant (MDR)
Candida albicans
and
Candida glabrata
Isolates
K. Borroto-Esoda, D. Angulo, S. Moser, J. Whiddon, P. Pappas, S. Wring
13th American Society for Microbiology (ASM) Conference on Candida and Candidiasis
April 2016
SCY-078 Displays Potent
In Vitro
Activity Against
Candida glabrata
Isolates with Mutations in
fks
Gene
K. Borroto-Esoda, D. Angulo, M. Castanheira, M. Pfaller, S. Wring
13th American Society for Microbiology (ASM) Conference on Candida and Candidiasis
< Prev
Next >
×